Resultados de procura - Luping Lin
- Mostrando 1 - 15 Resultados de 15
-
1
-
2
-
3
-
4
-
5
Resuscitating Cancer Immunosurveillance: Selective Stimulation of DLL1-Notch Signaling in T cells Rescues T-cell Function and Inhibits Tumor Growth por Yuhui Huang, Luping Lin, Anil Shanker, Anshu Malhotra, Li Yang, Mikhail M. Dikov, David P. Carbone
Publicado 2011Artigo -
6
Vitamin D Status Is Negatively Correlated with Insulin Resistance in Chinese Type 2 Diabetes por Jie Zhang, Jianhong Ye, Gang Guo, Zhenhao Lan, Xing Li, Zhiming Pan, Xianming Rao, Zongji Zheng, Fangtao Luo, Luping Lin, Zhihua Lin, Yaoming Xue
Publicado 2016Artigo -
7
Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase <i>BRAF</i> -mutant lung cancer por Ross A. Okimoto, Luping Lin, Victor Olivas, Elton Chan, Evan Markegard, Andrey Rymar, Dana S. Neel, Xiaohong Chen, Golzar Hemmati, Gideon Bollag, Trever G. Bivona
Publicado 2016Artigo -
8
Effects of Cancer-Associated EPHA3 Mutations on Lung Cancer por Guanglei Zhuang, Wenqiang Song, Katherine Amato, Yoonha Hwang, Keunwook Lee, Mark Boothby, Fei Ye, Yan Guo, Yu Shyr, Luping Lin, David P. Carbone, Dana M. Brantley‐Sieders, Jin Chen
Publicado 2012Artigo -
9
DENV NS1 and MMP-9 cooperate to induce vascular leakage by altering endothelial cell adhesion and tight junction por Pan Pan, Geng Li, Miaomiao Shen, Zhenyang Yu, Weiwei Ge, Zizhao Lao, Yaohua Fan, Keli Chen, Zhihao Ding, Wenbiao Wang, Pin Wan, Muhammad Adnan Shereen, Zhen Luo, Xulin Chen, Qiwei Zhang, Luping Lin, Jianguo Wu
Publicado 2021Artigo -
10
Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer por Luping Lin, Saurabh Asthana, Elton Chan, Sourav Bandyopadhyay, Maria M. Martins, Victor Olivas, Jenny Yan, Luu Pham, Mingxue Michelle Wang, Gideon Bollag, David B. Solit, Eric A. Collisson, Charles M. Rudin, Barry S. Taylor, Trever G. Bivona
Publicado 2014Artigo -
11
NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer por Collin M. Blakely, Evangelos Pazarentzos, Victor Olivas, Saurabh Asthana, Jenny Yan, Irena Tan, Gorjan Hrustanovic, Elton Chan, Luping Lin, Dana S. Neel, W. H. Newton, Kathryn Bobb, Timothy Fouts, Jeffrey Meshulam, Matthew A. Gubens, David M. Jablons, Jeffrey R. Johnson, Sourav Bandyopadhyay, Nevan J. Krogan, Trever G. Bivona
Publicado 2015Artigo -
12
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer por Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos, Asmin Tulpule, Saurabh Asthana, Collin M. Blakely, Ross A. Okimoto, Luping Lin, Dana S. Neel, Amit J. Sabnis, Jennifer C. Flanagan, Elton Chan, Marileila Varella‐Garcia, Dara L. Aisner, Aria Vaishnavi, Sai‐Hong Ignatius Ou, Eric A. Collisson, Eiki Ichihara, Philip C. Mack, Christine M. Lovly, Niki Karachaliou, Rafael Rosell, Jonathan W. Riess, Robert C. Doebele, Trever G. Bivona
Publicado 2015Artigo -
13
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer por Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, Victor Olivas, Valerie Au, Thomas LaFramboise, Mohamed Abdel-Rahman, Xiaoqi Wang, Alan D. Levine, Jin Kyung Rho, Yun Jung Choi, Chang‐Min Choi, Sang-We Kim, Se Jin Jang, Young Soo Park, Woo Sung Kim, Dae Ho Lee, Jung‐Shin Lee, Vincent A. Miller, Maria E. Arcila, Marc Ladanyi, Philicia Moonsamy, Charles L. Sawyers, Titus J. Boggon, C. Patrick, Carlota Costa, Miquel Tarón, Rafael Rosell, Balázs Halmos, Trever G. Bivona
Publicado 2012Artigo -
14
Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor por Holly K. Koblish, Liangxing Wu, Liang‐Chuan S. Wang, Phillip C.C. Liu, Richard Wynn, Jonathan Rios‐Doria, Susan Spitz, Hao Liu, Alla Volgina, Nina Zolotarjova, Kanishk Kapilashrami, Elham Behshad, Maryanne Covington, Yan‐ou Yang, Jingwei Li, Sharon Diamond, Maxim Soloviev, Kevin O’Hayer, Stephen C. Rubin, Chrysi Kanellopoulou, Gengjie Yang, Mark Rupar, Darlise DiMatteo, Luping Lin, Christina Stevens, Yue Zhang, Pramod Thekkat, Ryan Geschwindt, Cindy Marando, Swamy Yeleswaram, Jeff Jackson, Peggy Scherle, Reid Huber, Wenqing Yao, Gregory Hollis
Publicado 2022Artigo -
15
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies por Luping Lin, Amit J. Sabnis, Elton Chan, Victor Olivas, Lindsay Cade, Evangelos Pazarentzos, Saurabh Asthana, Dana S. Neel, Jenny Yan, Xinyuan Lu, Luu Pham, Mingxue M Wang, Niki Karachaliou, María González Cao, José Luís Manzano, José Luis Ramírez, J.M. Sanchez Torres, Fiamma Buttitta, Charles M. Rudin, Eric A. Collisson, Alain P. Algazi, Eric M. Robinson, Iman Osman, Eva Muñoz‐Couselo, Javier Cortés, Dennie T. Frederick, Zachary A. Cooper, Martin McMahon, Antonio Marchetti, Rafael Rosell, Keith T. Flaherty, Jennifer A. Wargo, Trever G. Bivona
Publicado 2015Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Cancer
Cancer research
Medicine
Genetics
Cell biology
Lung cancer
Signal transduction
Biochemistry
Epidermal growth factor receptor
Gene
Internal medicine
Oncology
Immunology
Kinase
Chemistry
EGFR inhibitors
MAPK/ERK pathway
Adenocarcinoma
Cell cycle
Endocrinology
Gefitinib
Immune system
Inflammation
Melanoma
Metastatic melanoma
Oncogene
Receptor
Receptor tyrosine kinase
V600E